Skip to content
healthcare.dev
Get a free key

Lumizyme

NDC 58468-0160, ALGLUCOSIDASE ALFA, injection, powder, for solution, from Genzyme Corporation.

Product NDC
58468-0160
Status
Listed
Labeler
Genzyme Corporation
Dosage form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125291
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0160 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALGLUCOSIDASE ALFA5 mg/mL

Pharmacologic classes

Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC]; alpha-Glucosidases [CS]

Package NDCNDC-11Package
58468-0160-1584680160011 VIAL, SINGLE-USE in 1 CARTON (58468-0160-1) / 10.5 mL in 1 VIAL, SINGLE-USE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d6bfbc45-2d34-439e-8aad-59ee2d53d4df

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=58468-0160

Use it

Look up 58468-0160 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58468-0160 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58468-0160. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.